ADAR1 Capital Management »

Embrace Change Acquisitn Cor shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Embrace Change Acquisitn Cor (EMCGW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Embrace Change Acquisitn Cor

Tip: Access up to 7 years of quarterly data

All positions including Embrace Change Acquisitn Cor held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Embrace Change Acquisitn Cor by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $264 18k 0.01
2024-06-30 $378 18k 0.02
2024-03-31 $406 18k 0.02
2023-12-31 $234 18k 0.01

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Embrace Change Acquisitn Cor

Mangrove Partners
Clear Street
Atw Spac Management
Boothbay Fund Management
Polar Securities
Wolverine Asset Management
Context Capital Management
Hudson Bay Capital Management
Yakira Capital Management
Weiss Asset Management LP[1
CNH Partners
Shaolin Capital Management
Taconic Capital Advisors
Periscope Capital
Cowen And Company

View all funds holding Embrace Change Acquisitn Cor